SITRAVATINIB (MGCD516) AND NIVOLUMAB IN ORAL CAVITY CANCER WINDOW OPPORTUNITY STUDY (SNOW)

Registry ID

SNOW-001

Source registry

HEALTH_CANADA

Status

Closed

Study type

INTERVENTIONAL

Sponsor

PRINCESS MARGARET CANCER CENTRE

Start date

2018-08-30

Completion date

2022-01-17

Last update

2018-07-27

Conditions

• ORAL CAVITY CANCER

View on source registry